Sindbis virus replicase-based dna vaccine construct encoding fmdv-specific multivalent epitope gene: Studies on its immune responses in guinea pigs

Scandinavian Journal of Immunology

Volumn 76, Issue 4, 2012, Pages 345-353

  Dar, P A ^a   Ganesh, K ^a   Nagarajan, G ^b   Sarika, S ^a   Reddy, G R ^a   Suryanarayana, V V S ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b NATIONAL RESEARCH CENTRE ON CAMEL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; NEUTRALIZING ANTIBODY; SINDBIS VIRUS REPLICASE BASED DNA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FOOT AND MOUTH DISEASE; GENE EXPRESSION; GUINEA PIG; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO GENE TRANSFER; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SINDBIS VIRUS; TRANSGENE; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CRICETINAE; DNA, RECOMBINANT; DNA-DIRECTED DNA POLYMERASE; EPITOPES; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; GUINEA PIGS; INJECTIONS, INTRAMUSCULAR; MALE; SINDBIS VIRUS; VACCINATION; VACCINES, DNA; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84866281384     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02733.x     Document Type: Article

References (50)

1. Grubman MJ, Baxt B. Foot-and-mouth disease. Clin Microbiol Rev 2004;17:465-93.
2. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 1989;337:709-16.
3. Bittle JL, Houghten RA, Alexander H et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982;298:30-3.
4. van Lierop MJ, van Maanen K, Meloen RH, Rutten VP, de Jong MA, Hensen EJ. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology 1992;75:406-13.
5. Domingo E, Escarmís C, Baranowski E et al. Evolution of foot-and-mouth disease virus. Virus Res 2003;91:47-63.
6. Domingo E, Escarmis C, Martinez MA, Martinez-Salas E, Mateu MG. Foot-and-mouth disease virus populations are quasispecies. Curr Top Microbiol Immunol 1992;176:33-47.
7. Kitching RP, Knowles NJ, Samuel AR, Donaldson AI. Development of foot-and-mouth disease virus strain characterisation - a review. Trop Anim Health Prod 1989;21:153-66.
8. Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus. Virus Res 2003;91:65-80.
9. Doel TR. FMD vaccines. Virus Res 2003;91:81-99.
10. Rodriguez LL, Grubman MJ. Foot and mouth disease virus vaccines. Vaccine 2009;27 (Suppl. 4):D90-4.
11. Doel TR. Natural and vaccine induced immunity to FMD. Curr Top Microbiol Immunol 2005;288:103-31.
12. Ward G, Rieder E, Mason PW. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. J Virol 1997;71:7442-7.
13. Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol 1998;72:4454-7.
14. Wong HT, Cheng SC, Chan EW et al. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 2000;278:27-35.
15. Chockalingam AK, Thiyagarajan S, Govindasamy N et al. Study of a chimeric foot-and-mouth disease virus DNA vaccine containing structural genes of serotype O in a genome backbone of serotype Asia 1 in guinea pigs. Acta Virol 2010;54:189-95.
16. Beard C, Ward G, Rieder E, Chinsangaram J, Grubman MJ, Mason PW. Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J Biotechnol 1999;73:243-9.
17. Huang H, Yang Z, Xu Q et al. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine. Viral Immunol 1999;12:1-8.
18. Shieh JJ, Liang CM, Chen CY et al. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization. Vaccine 2001;19:4002-10.
19. Dubensky TW, Driver DA, Polo JM et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol 1996;70:508-19.
20. Leitner WW, Ying H, Driver DA, Dubensky TW, Restifo NP. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res 2000;60:51-5.
21. Deshpande MS, Ambagala TC, Hegde NR, Hariharan MJ, Navaratnam M, Srikumaran S. Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 2002;20:3744-51.
22. Kirman JR, Turon T, Su H et al. Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect Immun 2003;71:575-9.
23. Yu X, Xiao S, Fang L, Jiang Y, Chen H. Enhanced immunogenicity to food-and-mouth disease virus in mice vaccination with alphaviral replicon-based DNA vaccine expressing the capsid precursor polypeptide (P1). Virus Genes 2006;33:337-44.
24. Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljeström P. Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol 1998;16:562-5.
25. Hariharan MJ, Driver DA, Townsend K et al. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol 1998;72:950-8.
26. Kamrud KI, Hooper JW, Elgh F, Schmaljohn CS. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Virology 1999;263:209-19.
27. Ying H, Zaks TZ, Wang RF et al. Cancer therapy using a self-replicating RNA vaccine. Nat Med 1999;5:823-7.
28. Leitner WW, Ying H, Restifo NP. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 1999;18:765-77.
29. Castelli JC, Hassel BA, Wood KA et al. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 1997;186:967-72.
30. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-8.
31. Chelbi-Alix MK, Sripati CE. Ability of insulin and DsRNA to induce interferon system and Hsp 70 in fibroblast and epithelial cells in relation to their effects on cell growth. Exp Cell Res 1994;213:383-90.
32. Albert ML, Pearce SF, Francisco LM et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998;188:1359-68.
33. Nagarajan G, Ravikumar P, Ashok Kumar C, Reddy GR, Dechamma HJ, Suryanarayana VVS. Self replicating gene vaccine carrying P1-2A gene of FMDV serotype O and its effects on the immune responses of cattle. Indian J Virol 2011;22:50-8.
34. Nagarajan G, Kumar CA, Dechamma HJ, Reddy GR, Ganesh K. Cloning and expression of FMDV-VP1 immunoreactive peptide in trivalent form and its application as immunogen. Indian J Biotechnol 2008;7:472-7.
35. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
36. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci USA 1979;76:4350-4.
37. Suryanarayana VV, Venkataramanan R, Rao BU, Padayatty JD. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72. Biochem Int 1992;26:1003-16.
38. Reed LJ, Reed L. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-7.
39. Garmory HS, Brown KA, Titball RW. DNA vaccines: improving expression of antigens. Genet Vaccines Ther 2003;1:2.
40. Ryan MD, Drew J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J 1994;13:928-33.
41. Lundstrom K. Alphavirus-based vaccines. Curr Opin Mol Ther 2002;4:28-34.
42. Näslund TI, Kostic L, Nordström EK, Chen M, Liljeström P. Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines. Virol J 2011;8:36.
43. Dory D, Rémond M, Béven V, Cariolet R, Zientara S, Jestin A. Foot-and-mouth disease virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine. Antiviral Res 2009;83:45-52.
44. Driver DA, Latham EM, Polo JM et al. Layered amplification of gene expression with a DNA gene delivery system. Ann N Y Acad Sci 1995;772:261-4.
45. Driver DA, Polo JM, Belli BA, Banks TA, Hariharan M, Dubensky TW. Plasmid DNA-based alphavirus expression vectors for nucleic acid immunization. IDrugs 1998;1:678-85.
46. Rolls MM, Webster P, Balba NH, Rose JK. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 1994;79:497-506.
47. Terenzi F, deVeer MJ, Ying H, Restifo NP, Williams BR, Silverman RH. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors. Nucleic Acids Res 1999;27:4369-75.
48. Sellins K, Fradkin L, Liggitt D, Dow S. Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes. Mol Ther 2005;12:451-9.
49. Der SD, Yang YL, Weissmann C, Williams BR. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Nat Acad Sci USA 1997;94:3279-83.
50. Miller A, Center RJ, Stambas J et al. Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination. Vaccine 2008;26:5641-8.